Search the Health Library
Get the facts on diseases, conditions, tests and procedures.
I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
William B. Isaacs, Ph.D.
William Thomas Gerrard, Mario Anthony Duhon, and Jennifer and John Chalsty Professor of Urology
Professor of Urology
Research Interests: Hereditary prostate cancer; Molecular genetics and cell biology of prostate cancer
Contact for Research Inquiries
115 Marburg Building
600 N. Wolfe St
Baltimore, MD 21205 map
Dr. William B. Isaacs is a professor of urology and oncology at the Johns Hopkins School of Medicine. He is the William Thomas Gerrard, Mario Anthony Duhon and Jennifer and John Chalsty Professor of Urology. His primary research focus is hereditary prostate cancer.
Dr. Isaacs’ team is working to characterize consistent alterations in the structure and expression of the genome of human prostate cancer cells as a way to identify genes that are critical in the pathways of prostatic carcinogenesis. The goal of this research is to more effectively identify men at high risk for prostate cancer and to identify new prognostic and therapeutic markers that could lead to more effective management of this common disease.
Dr. Isaacs completed his undergraduate degree at Brown University and joined the Johns Hopkins staff as a lab technician for Donald Coffey, then director of the Brady Urological Research Laboratory. He received his doctorate from Johns Hopkins University in the Department of Pharmacology and Molecular Science. He left Hopkins to do a post-doctoral program at the University of Iowa, and returned in 1988 to join the faculty of the Department of Urology.
Dr. Isaacs is recognized as a leader in the field of hereditary prostate cancer research. He has won numerous national and international awards and is a member of Sigma Xi, the American Society for Cell Biology, the Society for Basic Urologic Research and the American Association for Cancer Research.
- William Thomas Gerrard, Mario Anthony Duhon, and Jennifer and John Chalsty Professor of Urology
- Professor of Urology
- Professor of Oncology
- Ph.D., Johns Hopkins University School of Medicine (Maryland) (1984)
Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, MD, 1979, Laboratory Technician; Department of Biochemistry, University of Iowa, Iowa City, IA, 1988, Postdoctoral Fellow; The Oncology Center, The Johns Hopkins University School of Medicine, Baltimore, MD, 1984, Postdoctoral Fellow
Research & Publications
Dr. Isaacs’ lab is working to characterize consistent alterations in the structure and expression of the genome of human prostate cancer cells as a means of identifying genes critical in the pathways of prostatic carcinogenesis. They are focusing on somatic genomic alterations occurring in sporadic prostate cancers, as well as germline variations that confer increases in prostate cancer risk. Both genome wide and candidate gene approaches are being pursued, and cancer associated changes in gene expression analyses of normal and malignant prostate cells are being cataloged as a complementary approach in these efforts.
As an approach to identify high-risk prostate cancer susceptibility alleles, the lab has identified a large number of families having multiple men affected with prostate cancer. Linkage analysis in these families has provided evidence of susceptibility genes located on chromosomes 1 and 8; RNASEL (1q24-25) and MSR1 (8p22) have been identified as candidate prostate cancer susceptibility genes on these chromosomes. The involvement of these genes in the innate immune system suggests an important role for genetic variability of host response in determining individual prostate cancer risk. Current efforts are aimed at characterizing the role of these genes in prostate carcinogenesis, and the identification of additional prostate cancer gene loci.
It is anticipated that this work will assist in providing more effective methodologies to identify men at high risk for this disease in general, and in particular to identify new markers of prognostic and therapeutic significance that could lead to more effective management of this common disease.
Selected PublicationsView all on Pubmed
Tan HL, Sood A, Rahimi HA, Wang W, Gupta N, Hicks J, Mosier S, Gocke CD, Epstein JI, Netto GJ, Liu W, Isaacs WB, De Marzo AM, Lotan TL. "Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma." Clin Cancer Res. 2014 Jan 27. [Epub ahead of print]
Hurwitz LM, Heaphy CM, Joshu CE, Isaacs WB, Konishi Y, De Marzo AM, Isaacs SD, Wiley KE, Platz EA, Meeker AK. "Telomere length as a risk factor for hereditary prostate cancer." Prostate. 2014 Apr;74(4):359-64. doi: 10.1002/pros.22755. Epub 2013 Nov 28.
Teerlink CC, Thibodeau SN, McDonnell SK, Schaid DJ, Rinckleb A, Maier C, Vogel W, Cancel-Tassin G, Egrot C, Cussenot O, Foulkes WD, Giles GG, Hopper JL, Severi G, Eeles R, Easton D, Kote-Jarai Z, Guy M, Cooney KA, Ray AM, Zuhlke KA, Lange EM, Fitzgerald LM, Stanford JL, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Isaacs WB, Wahlfors T, Tammela T, Schleutker J, Wiklund F, Grönberg H, Emanuelsson M, Carpten J, Bailey-Wilson J, Whittemore AS, Oakley-Girvan I, Hsieh CL, Catalona WJ, Zheng SL, Jin G, Lu L, Xu J; International Consortium for Prostate Cancer Genetics, Camp NJ, Cannon-Albright LA. "Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease." Hum Genet. 2013 Oct 26. [Epub ahead of print].
Beebe-Dimmer J, Isaacs WB, Zuhlke KA, Yee C, Walsh PC, Isaacs SD, Johnson AM, Ewing CE, Humphreys EB, Chowdhury WH, Montie JE, Cooney KA. "The Prevalence of the HOXB13 G84E Prostate Cancer Risk Allele in Men Treated with Radical Prostatectomy." BJU Int. 2013 Oct 21. doi: 10.1111/bju.12522. [Epub ahead of print]
Haffner MC, Mosbruger T, Esopi DM, Fedor H, Heaphy CM, Walker DA, Adejola N, Gürel M, Hicks J, Meeker AK, Halushka MK, Simons JW, Isaacs WB, De Marzo AM, Nelson WG, Yegnasubramanian S. "Tracking the clonal origin of lethal prostate cancer." J Clin Invest. 2013 Nov 1;123(11):4918-22. doi: 10.1172/JCI70354. Epub 2013 Oct 25.
Academic Affiliations & Courses
Graduate Program Affiliation
Pharmacology and Molecular Sciences
Activities & Honors
- Melvin Judkins Young Investigator Award, American Heart Association, 2002
- Young Investigator Award, XIX World Congress on Diseases of the Chest/64th Annual International Scientific Assembly of the American College of Chest Physicians, 1998
- Cecile Lehman Mayer Research Finalist, XIX World Congress on Diseases of the Chest/64th Annual International Scientific Assembly of the American College of Chest Physicians, 1998
- Best Radiology Poster, World Congress of Endourology, 1998
- American Association for Cancer Research
- American Society for Cell Biology
- American Urological Association
- Sigma Xi
- Society for Basic Urologic Research